Michael D. Pak

Array ( [id] => 6176172 [patent_doc_number] => 20110177611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'LIGAND BINDING DOMAINS OF NUCLEAR RECEPTORS IN CONTROLLABLE FORM AND METHODS INVOLVING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/675804 [patent_app_country] => US [patent_app_date] => 2008-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11436 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177611.pdf [firstpage_image] =>[orig_patent_app_number] => 12675804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514214 [patent_doc_number] => 20090214520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Soluble CLCA-1 and antagonists to CLCA-1' [patent_app_type] => utility [patent_app_number] => 12/222980 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7615 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214520.pdf [firstpage_image] =>[orig_patent_app_number] => 12222980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4554834 [patent_doc_number] => 07820791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'H+-gated ion channel' [patent_app_type] => utility [patent_app_number] => 12/189014 [patent_app_country] => US [patent_app_date] => 2008-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 11282 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820791.pdf [firstpage_image] =>[orig_patent_app_number] => 12189014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5508005 [patent_doc_number] => 20090081212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'USE AND TARGETING OF CD98 LIGHT-CHAIN PROTEINS IN THERAPIES FOR THYROID HORMONE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/182030 [patent_app_country] => US [patent_app_date] => 2008-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21324 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081212.pdf [firstpage_image] =>[orig_patent_app_number] => 12182030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 53591 [patent_doc_number] => 07767450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-03 [patent_title] => 'SLO2 and SLO4, novel potassium channel proteins from human brain' [patent_app_type] => utility [patent_app_number] => 12/177819 [patent_app_country] => US [patent_app_date] => 2008-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 11 [patent_no_of_words] => 30356 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/767/07767450.pdf [firstpage_image] =>[orig_patent_app_number] => 12177819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6608114 [patent_doc_number] => 20100323371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'STROMAL INTERACTING MOLECULE KNOCKOUT MOUSE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/668220 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 22705 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323371.pdf [firstpage_image] =>[orig_patent_app_number] => 12668220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6440930 [patent_doc_number] => 20100104530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'ANTI-VPAC1 ANTIBODIES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 12/452356 [patent_app_country] => US [patent_app_date] => 2008-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12507 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104530.pdf [firstpage_image] =>[orig_patent_app_number] => 12452356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6561945 [patent_doc_number] => 20100272737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Novel Peptides and Protein and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/665159 [patent_app_country] => US [patent_app_date] => 2008-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 29519 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272737.pdf [firstpage_image] =>[orig_patent_app_number] => 12665159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6292381 [patent_doc_number] => 20100239540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'Peptide Linked Cell Matrix Materials for Stem Cells and Methods of Using the Same' [patent_app_type] => utility [patent_app_number] => 12/663945 [patent_app_country] => US [patent_app_date] => 2008-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19212 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20100239540.pdf [firstpage_image] =>[orig_patent_app_number] => 12663945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8527628 [patent_doc_number] => 08304198 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Assay for detection of transient intracellular CA2+' [patent_app_type] => utility [patent_app_number] => 12/665599 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4973 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12665599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 111882 [patent_doc_number] => 07718606 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-18 [patent_title] => 'Methods for treating muscle diseases and disorders' [patent_app_type] => utility [patent_app_number] => 12/157614 [patent_app_country] => US [patent_app_date] => 2008-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 82 [patent_no_of_words] => 22526 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718606.pdf [firstpage_image] =>[orig_patent_app_number] => 12157614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4948989 [patent_doc_number] => 20080305115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Reduced-mass, long-acting dosage forms' [patent_app_type] => utility [patent_app_number] => 12/157368 [patent_app_country] => US [patent_app_date] => 2008-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23122 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305115.pdf [firstpage_image] =>[orig_patent_app_number] => 12157368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8625285 [patent_doc_number] => 08357780 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-22 [patent_title] => 'Polypeptides, antibody variable domains and antagonists methods for' [patent_app_type] => utility [patent_app_number] => 12/663498 [patent_app_country] => US [patent_app_date] => 2008-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 90 [patent_figures_cnt] => 80 [patent_no_of_words] => 56474 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12663498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458674 [patent_doc_number] => 20090258826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use' [patent_app_type] => utility [patent_app_number] => 12/154468 [patent_app_country] => US [patent_app_date] => 2008-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24074 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258826.pdf [firstpage_image] =>[orig_patent_app_number] => 12154468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446050 [patent_doc_number] => 20090047276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'METHODS FOR INCREASING CELL OR TISSUE REGENERATION IN A VERTEBRATE SUBJECT' [patent_app_type] => utility [patent_app_number] => 12/120422 [patent_app_country] => US [patent_app_date] => 2008-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 40528 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047276.pdf [firstpage_image] =>[orig_patent_app_number] => 12120422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4461452 [patent_doc_number] => 07879976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Method for stabilizing a protein' [patent_app_type] => utility [patent_app_number] => 12/109435 [patent_app_country] => US [patent_app_date] => 2008-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6783 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879976.pdf [firstpage_image] =>[orig_patent_app_number] => 12109435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 299704 [patent_doc_number] => 07537903 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'FGF21 upregulates expression of GLUT-1 in a βklotho-dependent manner' [patent_app_type] => utility [patent_app_number] => 12/107895 [patent_app_country] => US [patent_app_date] => 2008-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4060 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/537/07537903.pdf [firstpage_image] =>[orig_patent_app_number] => 12107895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792102 [patent_doc_number] => 20080293076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Method to improve barrier function of cell-cell junctions' [patent_app_type] => utility [patent_app_number] => 12/079688 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5987 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293076.pdf [firstpage_image] =>[orig_patent_app_number] => 12079688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379317 [patent_doc_number] => 20090191156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'GM-CSF COSMECEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/052670 [patent_app_country] => US [patent_app_date] => 2008-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21700 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191156.pdf [firstpage_image] =>[orig_patent_app_number] => 12052670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6455285 [patent_doc_number] => 20100189776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'ANTI-ANDROGEN PEPTIDES AND USES THEREOF IN CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 12/531415 [patent_app_country] => US [patent_app_date] => 2008-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14695 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20100189776.pdf [firstpage_image] =>[orig_patent_app_number] => 12531415 [rel_patent_id] =>[rel_patent_doc_number] =>)